UDR, Inc. (UDR) director reports stock purchase and 10-year option grant
Rhea-AI Filing Summary
UDR, Inc. director Katherine A. Cattanach reported acquiring additional equity in the company. On January 2, 2026, she acquired 4,088 shares of UDR common stock at $36.69 per share, bringing her directly held common stock to 98,699 shares following the transaction.
On the same date, she was granted a stock option to purchase 6,693 shares of UDR common stock at an exercise price of $36.69 per share, expiring on January 2, 2036. The filing notes that these stock options will vest on January 2, 2027. After this grant, she beneficially owned 28,436 derivative securities, all reported as directly held.
Positive
- None.
Negative
- None.
FAQ
What insider transaction did UDR (UDR) report for Katherine A. Cattanach?
UDR reported that director Katherine A. Cattanach acquired 4,088 shares of UDR common stock at $36.69 per share on January 2, 2026, increasing her directly held position to 98,699 shares.
What stock options were granted to the UDR (UDR) director in this Form 4?
The director received a stock option grant for 6,693 shares of UDR common stock with an exercise price of $36.69 per share. The options expire on January 2, 2036.
When do Katherine A. Cattanach’s new UDR (UDR) stock options vest?
The filing states that the stock options granted on January 2, 2026 will vest on January 2, 2027.
How many UDR (UDR) derivative securities does the director own after this transaction?
After the reported transaction, the director beneficially owned 28,436 derivative securities related to UDR, all reported as held directly.
What is the relationship of the reporting person to UDR (UDR)?
The reporting person, Katherine A. Cattanach, is identified in the filing as a Director of UDR, Inc.
Is the UDR (UDR) Form 4 filed by more than one reporting person?
No. The Form 4 indicates it is filed by one reporting person, covering transactions for director Katherine A. Cattanach only.